Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice

2008/10/30 by Michelle C. Janelsins, Michael A. Mastrangelo, Keigan M. Park +7 · 26 citations
Medicine · Neuroscience · Immunology and Microbiology · #Alzheimer's disease research and treatments #Neuroinflammation and Neurodegeneration Mechanisms #Immune Response and Inflammation

paper · pdf · doi:10.2353/ajpath.2008.080528

Cited by

• ADAM proteases in cytokine biology: Modulators of immune signaling, inflammation and cancer
• Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. [europepmc]
• ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. [europepmc]
• Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. [europepmc]
• LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. [europepmc]
• Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. [europepmc]
• Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. [europepmc]
• Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo. [europepmc]
• Epigenetic mechanisms in Alzheimer's disease. [europepmc]
• Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. [europepmc]
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. [europepmc]
• Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. [europepmc]
• The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. [europepmc]
• Progranulin mutations as risk factors for Alzheimer disease. [europepmc]
• Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. [europepmc]
• The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ. [europepmc]
• Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms. [europepmc]
• Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. [europepmc]
• Glial contributions to neurodegeneration in tauopathies. [europepmc]
• A New Venue of TNF Targeting. [europepmc]
• Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial. [europepmc]
• Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration. [europepmc]
• Intersection of pathological tau and microglia at the synapse. [europepmc]
• Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review. [europepmc]
• TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus. [europepmc]
• New insight into neurological degeneration: Inflammatory cytokines and blood-brain barrier. [europepmc]